- Q1 2024 MaxCyte Inc Earnings Call TranscriptMay 07, 2024$3.93 (+0.51%)Earnings
- Q4 2023 MaxCyte Inc Earnings Call TranscriptMar 12, 2024$3.98 (+0.25%)Earnings
- Q3 2023 MaxCyte Inc Earnings Call TranscriptNov 08, 2023$3.35 (-1.47%)Earnings
- Preliminary Q3 2023 MaxCyte Inc Earnings Call TranscriptOct 04, 2023$3.27 (+9.00%)Earnings
- Q2 2023 MaxCyte Inc Earnings Call TranscriptAug 09, 2023$4.36 (-2.68%)Earnings
- MaxCyte Inc at William Blair Growth Stock Conference TranscriptJun 08, 2023
- Q1 2023 MaxCyte Inc Earnings Call TranscriptMay 10, 2023$4.65 (-0.64%)Earnings
- Q4 2022 MaxCyte Inc Earnings Call TranscriptMar 15, 2023$4.2 (+2.69%)Earnings
- MaxCyte Inc at Cowen Health Care Conference TranscriptMar 07, 2023
- Q3 2022 MaxCyte Inc Earnings Call TranscriptNov 09, 2022$6.1 (-9.36%)Earnings
- MaxCyte Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q2 2022 MaxCyte Inc Earnings Call TranscriptAug 10, 2022$5.68 (+3.65%)Earnings
- MaxCyte Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 MaxCyte Inc Earnings Call TranscriptMay 09, 2022$4.84 (-4.35%)Earnings
- Q4 2021 MaxCyte Inc Earnings Call TranscriptMar 22, 2022$6.9 (+3.45%)Earnings
- MaxCyte Inc at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- MaxCyte Inc at ShareSoc Webinar TranscriptFeb 08, 2022
- MaxCyte Inc at Proactive ONE2ONE Virtual Forum TranscriptDec 02, 2021
- MaxCyte Inc at Stephens Investment Conference (Virtual) TranscriptNov 29, 2021
- Q3 2021 MaxCyte Inc Earnings Call TranscriptNov 10, 2021$10.7 (-7.68%)Earnings
- Q2 2021 MaxCyte Inc Earnings Call TranscriptSep 13, 2021Earnings
MaxCyte Inc at William Blair Growth Stock Conference Transcript
Good morning, everyone. Thanks for joining us for the final day of conference here, really pleased to have MaxCyte here presenting. My name is Matt Larew I cover MaxCyte for William Blair. Doug Doerfler, who is a Co-Founder, President, and CEO of the company will be presenting. Before we go into the presentation, two things, the breakout session is in Jenny B and then for a complete list of our disclosures, you can go to williamblair.com. Again very pleased to have MaxCyte here with us today. And with that, I will turn it over to Doug.
Thank you, Matt, and good morning, everyone. I'd like to thank the Blair team and thank you all for coming this morning. Sorry.
So we're listed on both the AIM in London and also Nasdaq. So please refer to our written statements.
Let me start off by saying that MaxCyte and our team are involved in enabling the majority of the advanced non-viral cell therapies in the clinic today. So we are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)